Update

U.K. Economy Grew 0.7% in Third Quarter, Matching Median Forecast
Tweet TWEET

India Equity Movers: Bharti Airtel, Ranbaxy, Reliance Industries

The following companies had unusual price changes in India trading. Stock symbols are in parentheses and share prices are as of the 3:30 p.m. close in Mumbai.

The Bombay Stock Exchange Sensitive Index, or Sensex, dropped 258.78, or 1.4 percent, to 18,210.58, the lowest in more than a month. The BSE 200 Index slid 1.4 percent to 2,249.40. The gauges fell for the ninth straight day.

Bharti Airtel Ltd. (BHARTI) retreated 3.2 percent to 357.9 rupees, its biggest fall in more than three months. India’s largest mobile-phone operator said fourth-quarter profit fell 31 percent after higher costs for network and advertising expenses eroded margins.

Canara Bank (CBK) fell 2.6 percent to 558.65 rupees, its lowest close in more than two months. The lender posted a net income of 8.99 billion rupees in the fourth quarter, missing analysts’ estimates of 11.2 billion rupees.

Jyothy Laboratories Ltd. (JYL) soared 8.1 percent to 223.25 rupees, the steepest advance since June 18. A global private equity fund is likely to buy at least 26 percent stake in the household-products maker for about $150 million, the Economic Times reported today, citing people it didn’t identify. The company said the report was “speculative” in an exchange filing.

Kotak Mahindra Bank Ltd. (KMB) climbed 2.2 percent to 422 rupees, its steepest advance in more than two weeks. The lender, controlled by Indian billionaire Uday Kotak, posted a 17 percent increase in fourth-quarter net income, according to an exchange filing.

NTPC Ltd. (NTPC IN) decreased 2.6 percent to 173.95 rupees, its lowest in more than a month. India will cancel five coal mining leases alloted to the country’s largest power producer for “slow or non-implementation” of the projects, according to an e-mailed statement from the coal ministry today.

Piramal Life Sciences Ltd. (PLSL) , a drug-research company, surged 9.9 percent to 104.1 rupees, its steepest climb in seven weeks. Piramal Healthcare Ltd. (PIHC) , which owns 17.88 percent of the Piramal Life, will consider a proposal to merge a unit of the company with itself, according to an exchange filing. Piramal Healthcare fell 0.5 percent to 458.5 rupees.

Ranbaxy Laboratories Ltd. (RBXY) plunged 6 percent to 426.35 rupees, its lowest close in almost 11 months. U.S. federal prosecutors are negotiating a settlement with India’s largest drugmaker by revenue that could result in fines and payments exceeding $1 billion, Fortune magazine reported, citing people with knowledge of the talks. The company declined to comment, according to an e-mailed statement.

Reliance Industries Ltd. (RIL) rose 1.1 percent to 949.95 rupees, its highest advance in a week. India’s biggest listed firm by market value plans to invest as much as $12 billion in the chemicals business, the Economic Times reported, citing an interview with Chairman Mukesh Ambani. It will also increase output of natural gas from the KG-D6 block after analyzing data for a few more quarters with the help of BP Plc, the newspaper said. Manoj Warrier, a Reliance Industries spokesman, declined to comment on the report.

Sundaram Clayton Ltd. (SDC IN) advanced 2.3 percent to 153.6 rupees. The auto-part maker’s net income for the three months ended March 31 more than trebled to 157.1 million rupees, according to an exchange filing.

Thermax Ltd. (TMX) slid 3.5 percent to 591.75 rupees, its lowest close in more than a month. The power equipment maker, which fell for the fifth day, was cut to “sell” from “hold” at Citigroup Inc., which cited a “muted” outlook for order inflows. The brokerage reduced its share-price estimate to 542 rupees from 698 rupees, analysts led by Deepal Delivala wrote in a report.

To contact the reporter on this story: Ameya Karve in Mumbai at akarve@bloomberg.net.

To contact the editor responsible for this story: Darren Boey at dboey@bloomberg.net.

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.